# Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis

Study · id `cardio:ct-nct01104311` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01104311](<https://clinicaltrials.gov/study/NCT01104311>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01104311

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 132 participants.

## Technical summary

Registry record NCT01104311. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2017-03-07.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 132 participants (enrolled count; ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Primary completion: 2014-04 (actual) (ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Results first posted: 2017-03-07 (ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT01104311, source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01104311-2017-03-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
- Acronym: STABLE-ICAS
- Condition: Brain Ischemia
- Intervention (Procedure): Aggressive BP lowering
- Intervention (Procedure): modest blood pressure lowering
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Pfizer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Pfizer (`cardio:org-pfizer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial (`cardio:pubmed-29847486`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7b5cea4307404b67966b1665ca6542d6b3e047853f67bbbee2cc5dbe6b198e11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
